Cargando…

Reporting and methodological quality of studies that use Mendelian randomisation in UK Biobank: a meta-epidemiological study

OBJECTIVES: To identify whether Mendelian randomisation (MR) studies are appropriately conducted and reported in enough detail for other researchers to accurately replicate and interpret them. DESIGN: Cross-sectional meta-epidemiological study. DATA SOURCES: Web of Science, EMBASE, PubMed and PsycIN...

Descripción completa

Detalles Bibliográficos
Autores principales: Gibson, Mark J, Spiga, Francesca, Campbell, Amy, Khouja, Jasmine N, Richmond, Rebecca C, Munafò, Marcus R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086297/
https://www.ncbi.nlm.nih.gov/pubmed/36600446
http://dx.doi.org/10.1136/bmjebm-2022-112006
_version_ 1785022120221212672
author Gibson, Mark J
Spiga, Francesca
Campbell, Amy
Khouja, Jasmine N
Richmond, Rebecca C
Munafò, Marcus R
author_facet Gibson, Mark J
Spiga, Francesca
Campbell, Amy
Khouja, Jasmine N
Richmond, Rebecca C
Munafò, Marcus R
author_sort Gibson, Mark J
collection PubMed
description OBJECTIVES: To identify whether Mendelian randomisation (MR) studies are appropriately conducted and reported in enough detail for other researchers to accurately replicate and interpret them. DESIGN: Cross-sectional meta-epidemiological study. DATA SOURCES: Web of Science, EMBASE, PubMed and PsycINFO were searched on 15 July 2022 for literature. ELIGIBILITY CRITERIA: Full research articles that conducted an MR analysis exclusively using individual-level UK Biobank data to obtain a causal estimate of the exposure–outcome relationship (for no more than ten exposures or outcomes). METHODS AND ANALYSIS: Data were extracted using a 25-item checklist relating to reporting and methodological quality (based on the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE)-MR reporting guidelines and the guidelines for performing MR investigations). Article characteristics, such as 2021 Journal Impact Factor, publication year, journal word limit/recommendation, whether the MR analysis was the primary analysis, open access status and whether reporting guidelines were followed, were also extracted. Descriptive statistics were calculated for each item, and whether article characteristics predicted overall article completeness was investigated with linear regression. RESULTS: 116 articles were included in this review. The proportion of articles which reported complete information/adequate methodology ranged from 3% to 100% across the different items. Palindromic variants, variant replication, missing data, associations of the instrumental variable with the exposure or outcome and bias introduced by two-sample methods used on a single sample were often not completely addressed (<11%). There was no clear evidence that article characteristics predicted overall completeness except for primary analysis status. CONCLUSIONS: The results identify areas in which the reporting and conducting of MR studies needs to be improved and also suggest researchers do not make use of supplementary materials to sufficiently report secondary analyses. Future research should focus on the quality of code and analyses, attempt direct replications and investigate the impact of the STROBE-MR specifically. STUDY REGISTRATION: https://osf.io/nwrdj
format Online
Article
Text
id pubmed-10086297
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-100862972023-04-12 Reporting and methodological quality of studies that use Mendelian randomisation in UK Biobank: a meta-epidemiological study Gibson, Mark J Spiga, Francesca Campbell, Amy Khouja, Jasmine N Richmond, Rebecca C Munafò, Marcus R BMJ Evid Based Med Original Research OBJECTIVES: To identify whether Mendelian randomisation (MR) studies are appropriately conducted and reported in enough detail for other researchers to accurately replicate and interpret them. DESIGN: Cross-sectional meta-epidemiological study. DATA SOURCES: Web of Science, EMBASE, PubMed and PsycINFO were searched on 15 July 2022 for literature. ELIGIBILITY CRITERIA: Full research articles that conducted an MR analysis exclusively using individual-level UK Biobank data to obtain a causal estimate of the exposure–outcome relationship (for no more than ten exposures or outcomes). METHODS AND ANALYSIS: Data were extracted using a 25-item checklist relating to reporting and methodological quality (based on the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE)-MR reporting guidelines and the guidelines for performing MR investigations). Article characteristics, such as 2021 Journal Impact Factor, publication year, journal word limit/recommendation, whether the MR analysis was the primary analysis, open access status and whether reporting guidelines were followed, were also extracted. Descriptive statistics were calculated for each item, and whether article characteristics predicted overall article completeness was investigated with linear regression. RESULTS: 116 articles were included in this review. The proportion of articles which reported complete information/adequate methodology ranged from 3% to 100% across the different items. Palindromic variants, variant replication, missing data, associations of the instrumental variable with the exposure or outcome and bias introduced by two-sample methods used on a single sample were often not completely addressed (<11%). There was no clear evidence that article characteristics predicted overall completeness except for primary analysis status. CONCLUSIONS: The results identify areas in which the reporting and conducting of MR studies needs to be improved and also suggest researchers do not make use of supplementary materials to sufficiently report secondary analyses. Future research should focus on the quality of code and analyses, attempt direct replications and investigate the impact of the STROBE-MR specifically. STUDY REGISTRATION: https://osf.io/nwrdj BMJ Publishing Group 2023-04 2022-12-08 /pmc/articles/PMC10086297/ /pubmed/36600446 http://dx.doi.org/10.1136/bmjebm-2022-112006 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
spellingShingle Original Research
Gibson, Mark J
Spiga, Francesca
Campbell, Amy
Khouja, Jasmine N
Richmond, Rebecca C
Munafò, Marcus R
Reporting and methodological quality of studies that use Mendelian randomisation in UK Biobank: a meta-epidemiological study
title Reporting and methodological quality of studies that use Mendelian randomisation in UK Biobank: a meta-epidemiological study
title_full Reporting and methodological quality of studies that use Mendelian randomisation in UK Biobank: a meta-epidemiological study
title_fullStr Reporting and methodological quality of studies that use Mendelian randomisation in UK Biobank: a meta-epidemiological study
title_full_unstemmed Reporting and methodological quality of studies that use Mendelian randomisation in UK Biobank: a meta-epidemiological study
title_short Reporting and methodological quality of studies that use Mendelian randomisation in UK Biobank: a meta-epidemiological study
title_sort reporting and methodological quality of studies that use mendelian randomisation in uk biobank: a meta-epidemiological study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086297/
https://www.ncbi.nlm.nih.gov/pubmed/36600446
http://dx.doi.org/10.1136/bmjebm-2022-112006
work_keys_str_mv AT gibsonmarkj reportingandmethodologicalqualityofstudiesthatusemendelianrandomisationinukbiobankametaepidemiologicalstudy
AT spigafrancesca reportingandmethodologicalqualityofstudiesthatusemendelianrandomisationinukbiobankametaepidemiologicalstudy
AT campbellamy reportingandmethodologicalqualityofstudiesthatusemendelianrandomisationinukbiobankametaepidemiologicalstudy
AT khoujajasminen reportingandmethodologicalqualityofstudiesthatusemendelianrandomisationinukbiobankametaepidemiologicalstudy
AT richmondrebeccac reportingandmethodologicalqualityofstudiesthatusemendelianrandomisationinukbiobankametaepidemiologicalstudy
AT munafomarcusr reportingandmethodologicalqualityofstudiesthatusemendelianrandomisationinukbiobankametaepidemiologicalstudy